India’s engineering exports promotion body, EEPC India, on 29 April, 2026 organised a roadshow to build momentum for the second edition of the Pharma MachTech & LabNext Expo 2026, bringing together industry leaders, policymakers and stakeholders to discuss the future of India’s pharmaceutical manufacturing ecosystem.
The expo is scheduled to be held from September 7-9, 2026 at Bharat Mandapam (Pragati Maidan) in New Delhi, India and will run alongside iPHEX, one of the country’s major global pharma exhibitions. Organisers said the event is expected to attract more than 200 exhibitors and over 10,000 visitors, covering an area of over 10,000 square metres.
The roadshow focused on India’s transition from a global supplier of generic medicines to an emerging innovation-driven hub, with participants highlighting the growing importance of pharma machinery and laboratory equipment in this shift. India’s pharmaceutical industry currently ranks third globally by volume and 14th by value, contributing about 1.7% to the country’s GDP. The sector is projected to grow from around USD 50 billion at present to USD 130 billion by 2030, with exports expected to play a key role.
Speaking at the seminar, Vimal Anand, Joint Secretary in the Department of Commerce, said the government would continue to support the sector but emphasised the need for industry-led investment.
“The government is there to provide all support, to handhold the industry, and to strengthen the industry. It is also important that the industry takes it upon itself to make the right investment in technology, machinery, and innovation and position India as an important hub for the Pharma Machinery sector,” he said.
He also urged companies to leverage free trade agreements and flagged the sector’s trade imbalance, noting that while exports have grown at a CAGR of 15.3%, imports have also risen at 10.5%, reflecting continued dependence on high-end equipment. Arvind Kukrety, Deputy Drug Controller at CDSCO, underlined the importance of regulatory compliance, stressing adherence to global standards and robust quality systems to enhance competitiveness in international markets.
EEPC India Chairman Pankaj Chadha said the upcoming expo would serve as a key platform for the sector, reflecting strong industry interest and growing opportunities in pharma manufacturing and allied technologies. India’s domestic pharma machinery sector is currently growing at an estimated 8-10% CAGR, though it continues to rely on imports for advanced equipment, a gap that stakeholders said needs to be addressed to sustain long-term growth.
Leave a Reply
You must be logged in to post a comment.